Cetuximab Is contraindicated in the perioperative treatment of colorectal liver metastases.
Authors
Primrose, JCunningham, D
Garden, O
Maughan, T
Pugh, S
Stanton, L
Falk, S
Rees, M
Finch-Jones, M
Valle, Juan W
O'Reilly, D
Hornbuckle, J
Hickish, T
Bridgewater, J
Affiliation
University of Southampton, Southampton, United KingdomIssue Date
2015-06-01
Metadata
Show full item recordCitation
Cetuximab Is contraindicated in the perioperative treatment of colorectal liver metastases. 2015: J Clin OncolJournal
Journal of Clinical OncologyDOI
10.1200/JCO.2014.60.1344PubMed ID
26033821Type
ArticleLanguage
enISSN
1527-7755ae974a485f413a2113503eed53cd6c53
10.1200/JCO.2014.60.1344
Scopus Count
Collections
Related articles
- Reply to J.N. Primrose et al and C.-H. Köhne.
- Authors: Nordlinger BM, Poston GJ, Goldberg RM
- Issue date: 2015 Jul 20
- Is Progression-Free Survival the Right End Point in Trials of Patients With Clearly Resectable, Borderline Resectable, and Unresectable Liver-Limited Colorectal Cancer?
- Authors: Köhne CH
- Issue date: 2015 Jul 20
- Should the results of the new EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver?
- Authors: Nordlinger B, Poston GJ, Goldberg RM
- Issue date: 2015 Jan 20
- Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study.
- Authors: Malik H, Khan AZ, Berry DP, Cameron IC, Pope I, Sherlock D, Helmy S, Byrne B, Thompson M, Pulfer A, Davidson B
- Issue date: 2015 Apr
- When more is worse in clinical research and clinical practice.
- Authors: Tassinari D, Tombesi P, Sartori S
- Issue date: 2010 Aug